These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2150587)

  • 21. Comparison of uterine, endometrial and ovarian blood flow by transvaginal color Doppler ultrasound in ovulatory and anovulatory cycles.
    Dogan O; Yildiz A; Temizkan O; Pulatoglu C
    Ginekol Pol; 2016; 87(8):581-4. PubMed ID: 27629133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rates of Anovulation in Adolescents and Young Adults with Moderate to Severe Primary Dysmenorrhea and Those without Primary Dysmenorrhea.
    Seidman LC; Brennan KM; Rapkin AJ; Payne LA
    J Pediatr Adolesc Gynecol; 2018 Apr; 31(2):94-101. PubMed ID: 29017868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic and pharmacodynamic investigations with monthly injectable contraceptive preparations.
    Aedo AR; Landgren BM; Johannisson E; Diczfalusy E
    Contraception; 1985 May; 31(5):453-69. PubMed ID: 4028723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives.
    Bassol S; Hernandez C; Nava MP; Trujillo AM; Luz de la Cruz D
    Contraception; 1995 May; 51(5):307-11. PubMed ID: 7628206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
    Katkam RR; Gopalkrishnan K; Chwalisz K; Schillinger E; Puri CP
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of transvaginal ultrasound in diagnosing the etiology of menometrorrhagia.
    Dodson MG
    J Reprod Med; 1994 May; 39(5):362-72. PubMed ID: 8064703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach.
    Lemay A; Faure N
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient satisfaction for levonorgestrel intrauterine system and norethisterone for treatment of dysfunctional uterine bleeding.
    Naqaish T; Rizvi F; Khan A; Afzal M
    J Ayub Med Coll Abbottabad; 2012; 24(1):23-6. PubMed ID: 23855088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study of danazol and norethisterone in dysfunctional uterine bleeding presenting as menorrhagia.
    Bonduelle M; Walker JJ; Calder AA
    Postgrad Med J; 1991 Sep; 67(791):833-6. PubMed ID: 1835005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A survey of different approaches to management of menstrual disturbances in women using injectable contraceptives.
    Fraser IS
    Contraception; 1983 Oct; 28(4):385-97. PubMed ID: 6230212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
    Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception.
    Belsey EM
    Contraception; 1988 Aug; 38(2):181-206. PubMed ID: 2971505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
    Xiao B; Zeng T; Wu S; Sun H; Xiao N
    Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
    Swenson I; Khan AR; Jahan FA
    Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation and management of abnormal uterine bleeding in premenopausal women.
    Sweet MG; Schmidt-Dalton TA; Weiss PM; Madsen KP
    Am Fam Physician; 2012 Jan; 85(1):35-43. PubMed ID: 22230306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysfunctional uterine bleeding.
    Boyd ME
    Can J Surg; 1986 Sep; 29(5):305-7. PubMed ID: 3019496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report.
    Contraception; 1983 Jul; 28(1):1-20. PubMed ID: 6226488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma levels of C-reactive protein, leptin and glycosaminoglycans during spontaneous menstrual cycle: differences between ovulatory and anovulatory cycles.
    Capobianco G; de Muro P; Cherchi GM; Formato M; Lepedda AJ; Cigliano A; Zinellu E; Dessole F; Gordini L; Dessole S
    Arch Gynecol Obstet; 2010 Aug; 282(2):207-13. PubMed ID: 20306065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gonadotropin releasing hormone agonist for chronic anovulatory uterine bleeding and severe anemia.
    Vercellini P; Fedele L; Maggi R; Vendola N; Bocciolone L; Colombo A
    J Reprod Med; 1993 Feb; 38(2):127-9. PubMed ID: 8445603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovulation inhibition following vaginal administration of pills containing norethindrone and mestranol.
    Coutinho EM; Silva AR; Carreira C; Barbosa I
    Contraception; 1984 Feb; 29(2):197-202. PubMed ID: 6723313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.